APO Research
Talk to an analyst

APO RESEARCH · REPORT

Huntington Disease Protein

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Huntington Disease Protein Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchHuntington Disease Protein Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington Disease Protein Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Huntington Disease Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington Disease Protein Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington Disease Protein Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Huntington Disease Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Huntington Disease Protein market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Huntington Disease Protein market include WAVE Life Sciences Ltd., Vybion, Inc., Voyager Therapeutics, Inc., UniQure N.V., Sangamo BioSciences, Inc., reMYND NV, nLife Therapeutics, S.L., Neurimmune Holding AG and Ionis Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Huntington Disease Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Huntington Disease Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Huntington Disease Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Huntington Disease Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Huntington Disease Protein Segment by Company

WAVE Life Sciences Ltd.

Vybion, Inc.

Voyager Therapeutics, Inc.

UniQure N.V.

Sangamo BioSciences, Inc.

reMYND NV

nLife Therapeutics, S.L.

Neurimmune Holding AG

Ionis Pharmaceuticals, Inc.

AFFiRiS AG

Huntington Disease Protein Segment by Type

P-301905

NLF-HD

NI-302

IONIS-HTTRx

Others

Huntington Disease Protein Segment by Application

Kennedy's Disease

Spinocerebellar Ataxia

Alzheimer's Disease

Others

Huntington Disease Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Huntington Disease Protein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Huntington Disease Protein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Huntington Disease Protein significant trends, drivers, influence factors in global and regions.

6. To analyze Huntington Disease Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington Disease Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington Disease Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington Disease Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Huntington Disease Protein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Huntington Disease Protein industry.

Chapter 3: Detailed analysis of Huntington Disease Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Huntington Disease Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Huntington Disease Protein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Huntington Disease Protein Industry Trends Table 2. Huntington Disease Protein Industry Drivers Table 3. Huntington Disease Protein Industry Opportunities and Challenges Table 4. Huntington Disease Protein Industry Restraints Table 5. Global Huntington Disease Protein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Huntington Disease Protein Revenue Share by Company (2021-2026) Table 7. Global Huntington Disease Protein Sales Volume by Company (k units) & (2021-2026) Table 8. Global Huntington Disease Protein Sales Volume Share by Company (2021-2026) Table 9. Global Huntington Disease Protein Average Price (US$/unit) of Company (2021-2026) Table 10. Global Huntington Disease Protein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Huntington Disease Protein Key Company Manufacturing Base & Headquarters Table 12. Global Huntington Disease Protein Company, Product Type & Application Table 13. Global Huntington Disease Protein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of P-301905 Table 18. Significant Companies of NLF-HD Table 19. Significant Companies of NI-302 Table 20. Significant Companies of IONIS-HTTRx Table 21. Significant Companies of Others Table 22. Global Huntington Disease Protein Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Huntington Disease Protein Sales Volume by Type (2021-2026) & (k units) Table 24. Global Huntington Disease Protein Sales Volume by Type (2027-2032) & (k units) Table 25. Global Huntington Disease Protein Sales Volume Share by Type (2021-2026) Table 26. Global Huntington Disease Protein Sales Volume Share by Type (2027-2032) Table 27. Global Huntington Disease Protein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Huntington Disease Protein Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Huntington Disease Protein Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Huntington Disease Protein Sales Value Share by Type (2021-2026) Table 31. Global Huntington Disease Protein Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Kennedy's Disease Table 33. Significant Companies of Spinocerebellar Ataxia Table 34. Significant Companies of Alzheimer's Disease Table 35. Significant Companies of Others Table 36. Global Huntington Disease Protein Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Huntington Disease Protein Sales Volume by Application (2021-2026) & (k units) Table 38. Global Huntington Disease Protein Sales Volume by Application (2027-2032) & (k units) Table 39. Global Huntington Disease Protein Sales Volume Share by Application (2021-2026) Table 40. Global Huntington Disease Protein Sales Volume Share by Application (2027-2032) Table 41. Global Huntington Disease Protein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Huntington Disease Protein Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Huntington Disease Protein Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Huntington Disease Protein Sales Value Share by Application (2021-2026) Table 45. Global Huntington Disease Protein Sales Value Share by Application (2027-2032) Table 46. Global Huntington Disease Protein Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Huntington Disease Protein Sales by Region (2021-2026) & (k units) Table 48. Global Huntington Disease Protein Sales Market Share by Region (2021-2026) Table 49. Global Huntington Disease Protein Sales by Region (2027-2032) & (k units) Table 50. Global Huntington Disease Protein Sales Market Share by Region (2027-2032) Table 51. Global Huntington Disease Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Huntington Disease Protein Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Huntington Disease Protein Sales Value Share by Region (2021-2026) Table 54. Global Huntington Disease Protein Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Huntington Disease Protein Sales Value Share by Region (2027-2032) Table 56. Global Huntington Disease Protein Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Huntington Disease Protein Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Huntington Disease Protein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 61. Global Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 62. Global Huntington Disease Protein Sales by Country (2027-2032) & (k units) Table 63. Global Huntington Disease Protein Sales Market Share by Country (2027-2032) Table 64. Global Huntington Disease Protein Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Huntington Disease Protein Sales Value Market Share by Country (2021-2026) Table 66. Global Huntington Disease Protein Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Huntington Disease Protein Sales Value Market Share by Country (2027-2032) Table 68. WAVE Life Sciences Ltd. Company Information Table 69. WAVE Life Sciences Ltd. Business Overview Table 70. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio Table 72. WAVE Life Sciences Ltd. Recent Development Table 73. Vybion, Inc. Company Information Table 74. Vybion, Inc. Business Overview Table 75. Vybion, Inc. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Vybion, Inc. Huntington Disease Protein Product Portfolio Table 77. Vybion, Inc. Recent Development Table 78. Voyager Therapeutics, Inc. Company Information Table 79. Voyager Therapeutics, Inc. Business Overview Table 80. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio Table 82. Voyager Therapeutics, Inc. Recent Development Table 83. UniQure N.V. Company Information Table 84. UniQure N.V. Business Overview Table 85. UniQure N.V. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. UniQure N.V. Huntington Disease Protein Product Portfolio Table 87. UniQure N.V. Recent Development Table 88. Sangamo BioSciences, Inc. Company Information Table 89. Sangamo BioSciences, Inc. Business Overview Table 90. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio Table 92. Sangamo BioSciences, Inc. Recent Development Table 93. reMYND NV Company Information Table 94. reMYND NV Business Overview Table 95. reMYND NV Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. reMYND NV Huntington Disease Protein Product Portfolio Table 97. reMYND NV Recent Development Table 98. nLife Therapeutics, S.L. Company Information Table 99. nLife Therapeutics, S.L. Business Overview Table 100. nLife Therapeutics, S.L. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio Table 102. nLife Therapeutics, S.L. Recent Development Table 103. Neurimmune Holding AG Company Information Table 104. Neurimmune Holding AG Business Overview Table 105. Neurimmune Holding AG Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Neurimmune Holding AG Huntington Disease Protein Product Portfolio Table 107. Neurimmune Holding AG Recent Development Table 108. Ionis Pharmaceuticals, Inc. Company Information Table 109. Ionis Pharmaceuticals, Inc. Business Overview Table 110. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio Table 112. Ionis Pharmaceuticals, Inc. Recent Development Table 113. AFFiRiS AG Company Information Table 114. AFFiRiS AG Business Overview Table 115. AFFiRiS AG Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. AFFiRiS AG Huntington Disease Protein Product Portfolio Table 117. AFFiRiS AG Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Huntington Disease Protein Distributors List Table 121. Huntington Disease Protein Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Huntington Disease Protein Product Image Figure 2. Global Huntington Disease Protein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Huntington Disease Protein Sales (2021-2032) & (k units) Figure 5. Global Huntington Disease Protein Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Huntington Disease Protein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. P-301905 Image Figure 10. NLF-HD Image Figure 11. NI-302 Image Figure 12. IONIS-HTTRx Image Figure 13. Others Image Figure 14. Global Huntington Disease Protein Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Huntington Disease Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Huntington Disease Protein Sales Volume Share by Type (2021-2032) Figure 17. Global Huntington Disease Protein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Huntington Disease Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Huntington Disease Protein Sales Value Share by Type (2021-2032) Figure 20. Kennedy's Disease Image Figure 21. Spinocerebellar Ataxia Image Figure 22. Alzheimer's Disease Image Figure 23. Others Image Figure 24. Global Huntington Disease Protein Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Huntington Disease Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Huntington Disease Protein Sales Volume Share by Application (2021-2032) Figure 27. Global Huntington Disease Protein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Huntington Disease Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Huntington Disease Protein Sales Value Share by Application (2021-2032) Figure 30. Global Huntington Disease Protein Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Huntington Disease Protein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Huntington Disease Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Huntington Disease Protein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 35. North America Huntington Disease Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Huntington Disease Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Huntington Disease Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 41. South America Huntington Disease Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Huntington Disease Protein Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Huntington Disease Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Huntington Disease Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Huntington Disease Protein Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Huntington Disease Protein Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • P-301905
  • NLF-HD
  • NI-302
  • IONIS-HTTRx
  • Others
Applications
  • Kennedy's Disease
  • Spinocerebellar Ataxia
  • Alzheimer's Disease
  • Others
Companies covered
  • WAVE Life Sciences Ltd.
  • Vybion, Inc.
  • Voyager Therapeutics, Inc.
  • UniQure N.V.
  • Sangamo BioSciences, Inc.
  • reMYND NV
  • nLife Therapeutics, S.L.
  • Neurimmune Holding AG
  • Ionis Pharmaceuticals, Inc.
  • AFFiRiS AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Huntington Disease Protein Sales Value (2021-2032)
  4. 1.2.2 Global Huntington Disease Protein Sales Volume (2021-2032)
  5. 1.2.3 Global Huntington Disease Protein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Huntington Disease Protein Market Dynamics
  1. 2.1 Huntington Disease Protein Industry Trends
  2. 2.2 Huntington Disease Protein Industry Drivers
  3. 2.3 Huntington Disease Protein Industry Opportunities and Challenges
  4. 2.4 Huntington Disease Protein Industry Restraints
3 Huntington Disease Protein Market by Company
  1. 3.1 Global Huntington Disease Protein Company Revenue Ranking in 2025
  2. 3.2 Global Huntington Disease Protein Revenue by Company (2021-2026)
  3. 3.3 Global Huntington Disease Protein Sales Volume by Company (2021-2026)
  4. 3.4 Global Huntington Disease Protein Average Price by Company (2021-2026)
  5. 3.5 Global Huntington Disease Protein Company Ranking (2024-2026)
  6. 3.6 Global Huntington Disease Protein Company Manufacturing Base and Headquarters
  7. 3.7 Global Huntington Disease Protein Company Product Type and Application
  8. 3.8 Global Huntington Disease Protein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Huntington Disease Protein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Huntington Disease Protein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Huntington Disease Protein Market by Type
  1. 4.1 Huntington Disease Protein Type Introduction
  2. 4.1.1 P-301905
  3. 4.1.2 NLF-HD
  4. 4.1.3 NI-302
  5. 4.1.4 IONIS-HTTRx
  6. 4.1.5 Others
  7. 4.2 Global Huntington Disease Protein Sales Volume by Type
  8. 4.2.1 Global Huntington Disease Protein Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Huntington Disease Protein Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Huntington Disease Protein Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Huntington Disease Protein Sales Value by Type
  12. 4.3.1 Global Huntington Disease Protein Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Huntington Disease Protein Sales Value by Type (2021-2032)
  14. 4.3.3 Global Huntington Disease Protein Sales Value Share by Type (2021-2032)
5 Huntington Disease Protein Market by Application
  1. 5.1 Huntington Disease Protein Application Introduction
  2. 5.1.1 Kennedy's Disease
  3. 5.1.2 Spinocerebellar Ataxia
  4. 5.1.3 Alzheimer's Disease
  5. 5.1.4 Others
  6. 5.2 Global Huntington Disease Protein Sales Volume by Application
  7. 5.2.1 Global Huntington Disease Protein Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Huntington Disease Protein Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Huntington Disease Protein Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Huntington Disease Protein Sales Value by Application
  11. 5.3.1 Global Huntington Disease Protein Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Huntington Disease Protein Sales Value by Application (2021-2032)
  13. 5.3.3 Global Huntington Disease Protein Sales Value Share by Application (2021-2032)
6 Huntington Disease Protein Regional Sales and Value Analysis
  1. 6.1 Global Huntington Disease Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Huntington Disease Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Huntington Disease Protein Sales by Region: 2021-2026
  4. 6.2.2 Global Huntington Disease Protein Sales by Region (2027-2032)
  5. 6.3 Global Huntington Disease Protein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Huntington Disease Protein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Huntington Disease Protein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Huntington Disease Protein Sales Value by Region (2027-2032)
  9. 6.5 Global Huntington Disease Protein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Huntington Disease Protein Sales Value (2021-2032)
  12. 6.6.2 North America Huntington Disease Protein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Huntington Disease Protein Sales Value (2021-2032)
  15. 6.7.2 Europe Huntington Disease Protein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Huntington Disease Protein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Huntington Disease Protein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Huntington Disease Protein Sales Value (2021-2032)
  21. 6.9.2 South America Huntington Disease Protein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Huntington Disease Protein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Huntington Disease Protein Sales Value Share by Country, 2025 VS 2032
7 Huntington Disease Protein Country-level Sales and Value Analysis
  1. 7.1 Global Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Huntington Disease Protein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Huntington Disease Protein Sales by Country (2021-2032)
  4. 7.3.1 Global Huntington Disease Protein Sales by Country (2021-2026)
  5. 7.3.2 Global Huntington Disease Protein Sales by Country (2027-2032)
  6. 7.4 Global Huntington Disease Protein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Huntington Disease Protein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Huntington Disease Protein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Huntington Disease Protein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Huntington Disease Protein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Huntington Disease Protein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WAVE Life Sciences Ltd.
  2. 8.1.1 WAVE Life Sciences Ltd. Company Information
  3. 8.1.2 WAVE Life Sciences Ltd. Business Overview
  4. 8.1.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio
  6. 8.1.5 WAVE Life Sciences Ltd. Recent Developments
  7. 8.2 Vybion, Inc.
  8. 8.2.1 Vybion, Inc. Company Information
  9. 8.2.2 Vybion, Inc. Business Overview
  10. 8.2.3 Vybion, Inc. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Vybion, Inc. Huntington Disease Protein Product Portfolio
  12. 8.2.5 Vybion, Inc. Recent Developments
  13. 8.3 Voyager Therapeutics, Inc.
  14. 8.3.1 Voyager Therapeutics, Inc. Company Information
  15. 8.3.2 Voyager Therapeutics, Inc. Business Overview
  16. 8.3.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio
  18. 8.3.5 Voyager Therapeutics, Inc. Recent Developments
  19. 8.4 UniQure N.V.
  20. 8.4.1 UniQure N.V. Company Information
  21. 8.4.2 UniQure N.V. Business Overview
  22. 8.4.3 UniQure N.V. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 UniQure N.V. Huntington Disease Protein Product Portfolio
  24. 8.4.5 UniQure N.V. Recent Developments
  25. 8.5 Sangamo BioSciences, Inc.
  26. 8.5.1 Sangamo BioSciences, Inc. Company Information
  27. 8.5.2 Sangamo BioSciences, Inc. Business Overview
  28. 8.5.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio
  30. 8.5.5 Sangamo BioSciences, Inc. Recent Developments
  31. 8.6 reMYND NV
  32. 8.6.1 reMYND NV Company Information
  33. 8.6.2 reMYND NV Business Overview
  34. 8.6.3 reMYND NV Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 reMYND NV Huntington Disease Protein Product Portfolio
  36. 8.6.5 reMYND NV Recent Developments
  37. 8.7 nLife Therapeutics, S.L.
  38. 8.7.1 nLife Therapeutics, S.L. Company Information
  39. 8.7.2 nLife Therapeutics, S.L. Business Overview
  40. 8.7.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio
  42. 8.7.5 nLife Therapeutics, S.L. Recent Developments
  43. 8.8 Neurimmune Holding AG
  44. 8.8.1 Neurimmune Holding AG Company Information
  45. 8.8.2 Neurimmune Holding AG Business Overview
  46. 8.8.3 Neurimmune Holding AG Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Neurimmune Holding AG Huntington Disease Protein Product Portfolio
  48. 8.8.5 Neurimmune Holding AG Recent Developments
  49. 8.9 Ionis Pharmaceuticals, Inc.
  50. 8.9.1 Ionis Pharmaceuticals, Inc. Company Information
  51. 8.9.2 Ionis Pharmaceuticals, Inc. Business Overview
  52. 8.9.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio
  54. 8.9.5 Ionis Pharmaceuticals, Inc. Recent Developments
  55. 8.10 AFFiRiS AG
  56. 8.10.1 AFFiRiS AG Company Information
  57. 8.10.2 AFFiRiS AG Business Overview
  58. 8.10.3 AFFiRiS AG Huntington Disease Protein Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AFFiRiS AG Huntington Disease Protein Product Portfolio
  60. 8.10.5 AFFiRiS AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Huntington Disease Protein Value Chain Analysis
  2. 9.1.1 Huntington Disease Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Huntington Disease Protein Sales Mode & Process
  6. 9.2 Huntington Disease Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Huntington Disease Protein Distributors
  9. 9.2.3 Huntington Disease Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst